We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Rheumatoid arthritis drug may cure condition

Posted
by DPS

A drug used to treat rheumatoid arthritis can, in some patients, actually cause the condition to disappear, according to research at Melbourne’s Cabrini Hospital. The key is getting patients started on the treatment early in the condition .

The rheumatoid arthritis drug, called Inflixamab, has led to pain and swelling being cut by a third and in some cases, actually put patients into remission. The drug switches off a molecule called TNF, which is found in large amounts in rheumatoid arthritis patients.

Doctors say the earlier patients can be treated, the more likely it is the drug will alter the disease, even if patients take them for the relatively short time of a year.

Inflixamab can’t reverse the damage that has been done, so early use is recommended. However, a year’s supply of the medication costs up to $30,000.In Australia, it is only subsidised when a patient’s disease becomes advanced and where other drugs have failed.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo